Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort.

Neurol Neuroimmunol Neuroinflamm · 2023 · PMC9679887 · PMID 36411080

Europe PMC DOI

hedged sentence

0.0950

closest p · 1.9× alpha

0.0950

boldest claim

The sentences

showed a trendp = 0.095so close (0.05 < p ≤ 0.1)

Notably, patients fulfilling NEDA-3 T1 status at y6 showed unchanged sNfL levels (y0, 4.9 pg/mL (3.3–8.1); y6, 5.4 pg/mL (4.1–6.8); Wilcoxon test, p = 0.955), whereas patients with EDA T1 , probably in terms of regression to the mean, 4 showed a trend toward a decrease in sNfL levels from 10.2 pg/mL (y0, 5.8–14.8) to 8.2 pg/mL (y6, 6.3–12.3; Wilcoxon test, p = 0.095; Figure 2B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.